The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111083347 11108334 7 F 2014 20160822 20150512 20160825 EXP PHHY2015AR057019 NOVARTIS 0.00 F Y 0.00000 20160825 CN COUNTRY NOT SPECIFIED AR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111083347 11108334 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, UNK 21008 20 MG
111083347 11108334 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Unknown 20 MG, UNK 21008 20 MG
111083347 11108334 3 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Unknown 20 MG, UNK 21008 20 MG
111083347 11108334 4 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 Unknown 20 MG, QD U 0 20 MG QD
111083347 11108334 5 C TOPIRAMATE. TOPIRAMATE 1 Unknown 25 MG, QD U 0 25 MG QD
111083347 11108334 6 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown U 0
111083347 11108334 7 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 2 DF, QD U 0 2 DF TABLET QD
111083347 11108334 8 C CABERGOLINE. CABERGOLINE 1 Unknown Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111083347 11108334 1 Acromegaly
111083347 11108334 4 Product used for unknown indication
111083347 11108334 5 Product used for unknown indication
111083347 11108334 6 Product used for unknown indication
111083347 11108334 7 Diabetes mellitus
111083347 11108334 8 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
111083347 11108334 HO
111083347 11108334 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
111083347 11108334 Amenorrhoea
111083347 11108334 Anaemia
111083347 11108334 Arthralgia
111083347 11108334 Bronchial disorder
111083347 11108334 Diabetes insipidus
111083347 11108334 Fatigue
111083347 11108334 Feeling abnormal
111083347 11108334 Gait disturbance
111083347 11108334 Headache
111083347 11108334 Hormone level abnormal
111083347 11108334 Hypertension
111083347 11108334 Hypoaesthesia
111083347 11108334 Hypoglycaemia
111083347 11108334 Malaise
111083347 11108334 Muscle spasms
111083347 11108334 Neoplasm progression
111083347 11108334 Nose deformity
111083347 11108334 Osteoarthritis
111083347 11108334 Pain in extremity
111083347 11108334 Paraesthesia
111083347 11108334 Peripheral swelling
111083347 11108334 Pollakiuria
111083347 11108334 Sensory disturbance
111083347 11108334 Swelling
111083347 11108334 Swelling face
111083347 11108334 Tension
111083347 11108334 Throat tightness
111083347 11108334 Tremor
111083347 11108334 Vaginal haemorrhage
111083347 11108334 Weight decreased
111083347 11108334 Weight increased
111083347 11108334 Weight loss poor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111083347 11108334 1 201412 201412 0
111083347 11108334 2 201505 201602 0
111083347 11108334 3 201603 0